The osteolytic bone metastasis mode, most common for breast cancer bone metastases, is distinguished by osteoclastic bone destruction induced by IL-11, coupled with promotion of tumor growth and osteoblast proliferation driven by angiogenesis through the connective tissue growth factor (CTGF) [20]. This evidence concerns the gene CCN2 and breast carcinoma.